Rejuvenon
About:
Rejuvenon a biopharmaceutical company committed developing and commercializing promising compounds for treatment of oncologic diseases.
Website: http://rejuvenon.com/
Top Investors: OrbiMed, Boston Millennia Partners, Prospect Venture Partners, Schroder Ventures, BCM Technologies (BCMT)
Description:
Rejuvenon a biopharmaceutical company committed developing and commercializing promising compounds for treatment of oncologic diseases.
Total Funding Amount:
$49M
Headquarters Location:
The Woodlands, Texas, United States
Founded Date:
2000-01-01
Founders:
Matthias Steger
Number of Employees:
1-10
Last Funding Date:
2004-06-23
IPO Status:
Private
Industries:
© 2025 bioDAO.ai